A combined IHC panel of beta catenin, LEF1 and TFE3 resulted in a sensitivity and specificity of 100 and 91.9% in distinguishing SPNs from ductal adenocarcinomas and Pan NETs. Here, TFE3 is linked to invasive ductal breast carcinoma.